Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has issued an announcement.
Resmed Inc has filed a notice for the proposed sale of securities under Rule 144, with Michael J. Farrell, an officer and director of the company, planning to sell 8,009 common shares. The aggregate market value of these shares is approximately $1.8 million, and the sale is scheduled for March 7, 2025. This transaction is part of a planned trading strategy, and the company has ensured that no material adverse information is undisclosed, maintaining transparency with stakeholders.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Resmed Inc is a company operating in the healthcare industry, primarily focused on providing medical equipment and services. The company specializes in products related to sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions, serving a global market with innovative solutions.
YTD Price Performance: -2.20%
Average Trading Volume: 1,054,383
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$54.31B
For an in-depth examination of RMD stock, go to TipRanks’ Stock Analysis page.